These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 24175986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA.
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [Abstract] [Full Text] [Related]

  • 3. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
    Tsouana E, Kaya B, Gadong N, Hemmaway C, Newell H, Simmons A, Whitmarsh S, Telfer P.
    Eur J Haematol; 2015 Apr; 94(4):336-42. PubMed ID: 25138173
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [Abstract] [Full Text] [Related]

  • 5. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT.
    Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E.
    Pediatr Blood Cancer; 2007 Sep 01; 49(3):329-32. PubMed ID: 17554789
    [Abstract] [Full Text] [Related]

  • 8. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD.
    Am J Hematol; 2014 Apr 01; 89(4):391-4. PubMed ID: 24347294
    [Abstract] [Full Text] [Related]

  • 9. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL, Cohen AR, Garro J, Alvarez O, Nagasubramanian R, Sarnaik S, Thompson A, Woods GM, Schultz W, Mortier N, Lane P, Mueller B, Yovetich N, Ware RE, SWiTCH Study Investigators.
    Am J Hematol; 2012 Feb 01; 87(2):221-3. PubMed ID: 22120913
    [Abstract] [Full Text] [Related]

  • 10. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F, Höchsmann B, Giagounidis A, Lübbert M, Platzbecker U, Haase D, Lück A, Gattermann N, Taupitz M, Baier M, Leismann O, Junkes A, Schumann C, Hofmann WK, Schrezenmeier H.
    Ann Hematol; 2013 Jan 01; 92(2):191-8. PubMed ID: 23073603
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M, Ou P, Elie C, Canniffe C, Kutty S, Delos V, Graffigne C, de Montalembert M, Brousse V.
    J Pediatr Hematol Oncol; 2016 Oct 01; 38(7):497-502. PubMed ID: 27548334
    [Abstract] [Full Text] [Related]

  • 12. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
    Vitrano A, Calvaruso G, Tesé L, Gioia F, Cassarà F, Campisi S, Butera F, Commendatore V, Rizzo M, Santoro V, Cigna V, Quota A, Bagnato S, Argento C, Fidone C, Schembari D, Gerardi C, Barbiera F, Bellisssima G, Giugno G, Polizzi G, Rosso R, Abbate G, Caruso V, Chiodi E, Gamberini MR, Giorgi B, Putti MC, Filosa A, De Ritis MR, Oliva E, Arcadi N, Fustaneo M, Mistretta L, Di Maggio R, Sacco M, Veronica DS, Giangreco A, Maggio A.
    Eur J Haematol; 2016 Oct 01; 97(4):361-70. PubMed ID: 26818147
    [Abstract] [Full Text] [Related]

  • 13. Ferritin and LIC: predicting liver injury in children with sickle cell.
    Smith E, Lebensburger J, Hilliard L, Kelly D, Fineberg N, Bai S, Howard T.
    J Pediatr Gastroenterol Nutr; 2014 Mar 01; 58(3):387-90. PubMed ID: 24553473
    [Abstract] [Full Text] [Related]

  • 14. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC, Cohen AR, Pressel SL, Aygun B, Imran H, Luchtman-Jones L, Thompson AA, Fuh B, Schultz WH, Davis BR, Ware RE, TWiTCH Investigators.
    Br J Haematol; 2016 Jan 01; 172(1):122-30. PubMed ID: 26523836
    [Abstract] [Full Text] [Related]

  • 15. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
    Cheong JW, Kim HJ, Lee KH, Yoon SS, Lee JH, Park HS, Kim HY, Shim H, Seong CM, Kim CS, Chung J, Hyun MS, Jo DY, Jung CW, Sohn SK, Yoon HJ, Kim BS, Joo YD, Park CY, Min YH, Korean Society of Hematology Acute Myeloid Leukemia/Myelodysplastic Syndrome Working Party.
    Transfusion; 2014 Jun 01; 54(6):1542-51. PubMed ID: 24313463
    [Abstract] [Full Text] [Related]

  • 16. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.
    Br J Haematol; 2007 Sep 01; 138(5):587-93. PubMed ID: 17610536
    [Abstract] [Full Text] [Related]

  • 17. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB, Disco D, Jackson SM, Lewin D, McKie V, Baker RD, Baker SS, Laver JH, Nietert PJ, Abboud MR.
    Pediatr Blood Cancer; 2008 Jan 01; 50(1):62-5. PubMed ID: 17457853
    [Abstract] [Full Text] [Related]

  • 18. Nontransferrin-bound iron in transfused patients with sickle cell disease.
    Inati A, Musallam KM, Cappellini MD, Duca L, Taher AT.
    Int J Lab Hematol; 2011 Apr 01; 33(2):133-7. PubMed ID: 21382180
    [Abstract] [Full Text] [Related]

  • 19. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May 01; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

  • 20. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.
    J Pediatr Hematol Oncol; 2009 May 01; 31(5):309-12. PubMed ID: 19415007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.